Strides Pharma Science Limited (NSE:STAR)
India · Delayed Price · Currency is INR 1,001.85
+5.35 (0.54%)
Apr 21, 2026, 2:11 PM IST
Strides Pharma Science Market Cap
Strides Pharma Science has a market cap or net worth of 91.85 billion as of April 20, 2026. Its market cap has increased by 46.10% in one year.
Market Cap
91.85B
Enterprise Value
108.48B
Revenue
47.26B
Ranking
n/a
PE Ratio
17.96
Stock Price
1,001.85
Market Cap Chart
Since February 2, 2000, Strides Pharma Science's market cap has increased from 7.49B to 91.85B, an increase of 1,125.65%. That is a compound annual growth rate of 10.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 20, 2026 | 91.85B | 10.68% |
| Dec 31, 2025 | 82.99B | 36.56% |
| Dec 31, 2024 | 60.77B | 1.87% |
| Dec 29, 2023 | 59.66B | 88.83% |
| Dec 30, 2022 | 31.59B | -21.29% |
| Dec 31, 2021 | 40.14B | -49.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NATCO Pharma | 200.55B |
| Eris Lifesciences | 200.26B |
| Piramal Pharma | 197.65B |
| Alembic Pharmaceuticals | 154.25B |
| Cohance Lifesciences | 149.41B |
| Alivus Life Sciences | 131.28B |
| Akums Drugs and Pharmaceuticals | 83.56B |
| Sudeep Pharma | 72.90B |